AstraZeneca and its research and development subsidiary, MedImmune, announced this week that the United States Food and Drug Administration (FDA) has granted durvalumab (MEDI4736) Breakthrough Therapy designation (BTD). Read More »

BioPlus Specialty Pharmacy has announced that its Pay it Forward program will be extended into 2016. Read More »

Amgen announced this week that the Phase 3 Aranesp (darbepoetin alfa) ARCADE trial succeeded in reducing the occurrence of red blood cell transfusions for patients with low and intermediate-1 risk Myelodysplastic Syndrome (MDS) who are also anemic. Read More »

BodyMcKesson announced this week that KLAS, an independent health research firm, has named McKesson Labs 2015/2016 Best in KLAS for Laboratory. Read More »

Daiichi Sankyo Co. announced last week that its oncolytic virus (G47) has received designation under the SAKIGATE Designation System for medical equipment, in vitro diagnostic pharmaceuticals and regenerative medicinal products. Read More »

Aetna and Mount Sinai Health Partners, a group that consists of Mount Sinai Health Systems and volunteers, have announced that the two organizations have come together to form a partnership with the goal of improving coordinated care for patients and decreasing health care costs. Read More »

Actinium Pharmaceuticals announced this week that it will be sending personnel from clinical and business development to the annual BMT Tandem Meetings held by the Center for International Blood & Marrow Transplant Research (CIBMTR) and the American Society of Blood and Marrow Transplantation (ASBMT). Read More »

Pfizer has announced that an agreement has been reached by its subsidiary, Wyeth, to resolve claims that its practice in calculating Medicaid rebates violated the Federal Civil False Claims Act and other laws. Read More »

The Cigna Foundation announced last week that it plans to make Community Health Navigation a priority moving forward with its World of Difference grants in the United States. Read More »

Florida Accountable Care Services (FACS) and UnitedHealthcare announced this week a joint-collaboration to introduce an accountable care program to help the enhancement of patients’ health and overall health care satisfaction. Read More »

Aetna, a nationwide leader in diversified health care benefits, has announced this week that it has purchased Humana’s affiliates located in Florida. Read More »

Renewed calls for a federal ban on prescription drug advertising to consumers needs to be squashed immediately, the Association of National Advertisers (ANA) says. Read More »

US Oncology Research announced recently that it has found and recruited its 2,000th patient to take part in a Phase I clinical trial through its Translational Oncology Program (TOP). Read More »

Upsher-Smith Laboratories Inc. and the National Alliance of State Pharmacy Associations (NASPA) have partnered to honor 43 pharmacists from across the United States with the 2015 NASPA Excellence in Innovation Award. Read More »

Eisai Co. and Sysmex Corp. made a joint announcement this week declaring that the two companies have agreed on a non-exclusive partnership to develop new diagnostics for the field of dementia. Read More »

Sandoz, a company owned by Novartis, announced last week that it has procured the rights to develop and commercialize PF_06438179 (infliximab) from Pfizer. Read More »

Chattem Inc., a subsidiary of Sanofi, announced last week that its product, ACT Advanced Care Mouthwash, has been named the recipient of the 2016 Product of the Year award. Read More »

The National Association of Chain Drug Stores (NACDS) is pleased with the momentum the proposed bill to combat prescription drug abuse, which cleared the U.S. Senate Judiciary Committee this week, is gaining. Read More »

AstraZeneca announced this week that it, along with its worldwide biologics research and development subsidiary, MedImmune, have entered into an agreement to partner with the University of Michigan and Eli Lilly to develop new therapeutic drugs to treat chronic kidney disease (CKD). Read More »

Sandoz announced this week that the Marketing Authorization Application (MAA) for its biosimilar to Amgen’s EU-licensed Neulasta (pegfilgrastim) has been accepted by the European Medicines Agency (EMA). Read More »